Personalized Treatment Approach to Metastatic Castration-Resistant Prostate Cancer with BRCA2 and PTEN Mutations: A Case Report

Personalized Treatment Approach to Metastatic Castration-Resistant Prostate Cancer with BRCA2 and PTEN Mutations: A Case Report

DNA repair mutations (BRCA1 and BRCA2) are found in metastatic castration-resistant prostate cancer (CRPC) patients. Here, we report a case of a 71-year-old male patient with metastatic CRPC along with BRCA2 and PTEN mutations. As per the genomic findings of the Foundation One report, FDA-approved t...

Full description

Bibliographic Details
Main Authors: Pramod Kumar Julka, Amit Verma, Kush Gupta
Format: Article
Language:English
Published: Karger Publishers 2020-02-01
Series:Case Reports in Oncology
Subjects:
crpc
brca2
pten
olaparib
prostate cancer
Online Access:https://www.karger.com/Article/FullText/505182

Similar Items

Similar Items